Male Birth Control on the Horizon

A new male contraceptive gel designed to be less invasive than a vasectomy has been found to work successfully in primates.

Vasalgel Male Contraceptive / Image: Parsemus Foundation
Vasalgel Male Contraceptive / Image: Parsemus Foundation

A recent article from The Guardian suggests men will soon be able to take on the burden of birth control. A new product called Vasalgel was found to be 100% effective at preventing conception in rhesus monkeys. The non-hormonal contraceptive is designed to be reversible and less invasive than a vasectomy. Once injected, it forms a soft gel barrier that blocks sperm from passing through the Vas deferens. Sperm are too large to pass through the gel and are reabsorbed into the body; neither sperm production nor hormone levels are affected.

Last year, The World Health Organization investigated a male hormonal contraceptive jab that claimed to be as effective as the female pill, but a variety of unwanted side effects prevented the product from launching

The Vasalgel work was funded by The Parsemus Foundation, a non-profit that plans to begin human trials once funding is secured.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026